BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 3808575)

  • 1. Comparison of the effects of fermented and unfermented mistletoe preparations on cultured tumor cells.
    Ribéreau-Gayon G; Jung ML; Di Scala D; Beck JP
    Oncology; 1986; 43 Suppl 1():35-41. PubMed ID: 3808575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of cytotoxic proteins from mistletoe (Viscum album L.).
    Jung ML; Baudino S; Ribéreau-Gayon G; Beck JP
    Cancer Lett; 1990 May; 51(2):103-8. PubMed ID: 2344587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of mistletoe (Viscum album L.) extracts on cultured tumor cells.
    Ribéreau-Gayon G; Jung ML; Baudino S; Sallé G; Beck JP
    Experientia; 1986 Jun; 42(6):594-9. PubMed ID: 3013672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a toxic lectin in Iscador, a mistletoe preparation with alleged cancerostatic properties.
    Holtskog R; Sandvig K; Olsnes S
    Oncology; 1988; 45(3):172-9. PubMed ID: 3368193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection and quantitative determination of lectins and viscotoxins in mistletoe preparations].
    Jordan E; Wagner H
    Arzneimittelforschung; 1986 Mar; 36(3):428-33. PubMed ID: 3707660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of carbohydrates on the cytotoxicity of an aqueous mistletoe drug and of purified mistletoe lectins tested on human T-leukemia cells.
    Doser C; Doser M; Hülsen H; Mechelke F
    Arzneimittelforschung; 1989 Jun; 39(6):647-51. PubMed ID: 2775329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the standardization of mistletoe preparations.
    Wagner H; Jordan E; Feil B
    Oncology; 1986; 43 Suppl 1():16-22. PubMed ID: 3027640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiles of different breast cancer cells compared with their responsiveness to fermented mistletoe (Viscum album L.) extracts Iscador from oak (Quercus), pine (Pinus), white fir (Abies) and apple tree (Malus) in vitro.
    Eggenschwiler J; Patrignani A; Wagner U; Rehrauer H; Schlapbach R; Rist L; Ramos MH; Viviani A
    Arzneimittelforschung; 2006 Jun; 56(6A):483-96. PubMed ID: 16927530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a preparation from Viscum album on tumor development in vitro and in mice.
    Kuttan G; Vasudevan DM; Kuttan R
    J Ethnopharmacol; 1990 Apr; 29(1):35-41. PubMed ID: 2345458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and identification of a tumour reducing component from mistletoe extract (Iscador).
    Kuttan G; Vasudevan DM; Kuttan R
    Cancer Lett; 1988 Aug; 41(3):307-14. PubMed ID: 3409209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of tumor growth stimulation in a panel of 16 human tumor cell lines by mistletoe extracts in vitro.
    Maier G; Fiebig HH
    Anticancer Drugs; 2002 Apr; 13(4):373-9. PubMed ID: 11984083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of cytotoxicity and enhancement of cytokine release induced by Viscum album L. extracts or mistletoe lectins.
    Ribéreau-Gayon G; Jung ML; Frantz M; Anton R
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S3-8. PubMed ID: 9179359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cancer cells exhibit in vitro individual receptiveness towards different mistletoe extracts.
    Knöpfl-Sidler F; Viviani A; Rist L; Hensel A
    Pharmazie; 2005 Jun; 60(6):448-54. PubMed ID: 15997835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of tumor growth stimulation in a panel of 26 human tumor cell lines by mistletoe (Viscum album L.) extracts Iscador in vitro.
    Kelter G; Fiebig HH
    Arzneimittelforschung; 2006 Jun; 56(6A):435-40. PubMed ID: 16927523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of mistletoe (Viscum album L.) extracts Iscador on cell cycle and survival of tumor cells.
    Harmsma M; Ummelen M; Dignef W; Tusenius KJ; Ramaekers FC
    Arzneimittelforschung; 2006 Jun; 56(6A):474-82. PubMed ID: 16927529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of cytokines by a fermented lectin-1 (ML-1) free mistletoe extract reflects differences in the reactivity of PBMC in healthy and allergic individuals and tumour patients.
    Stein GM; Meink H; Durst J; Berg PA
    Eur J Clin Pharmacol; 1996; 51(3-4):247-52. PubMed ID: 9010693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viscotoxins, mistletoe lectins and their isoforms in mistletoe (Viscum album L.) extracts Iscador.
    Urech K; Schaller G; Jäggy C
    Arzneimittelforschung; 2006 Jun; 56(6A):428-34. PubMed ID: 16927522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleura carcinosis. Cytomorphological findings with the mistletoe preparation iscador and other pharmaceuticals.
    Salzer G
    Oncology; 1986; 43 Suppl 1():66-70. PubMed ID: 3808576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-lectin component in a fermented extract from Viscum album L. grown on pines induces proliferation of lymphocytes from healthy and allergic individuals in vitro.
    Stein G; Berg PA
    Eur J Clin Pharmacol; 1994; 47(1):33-8. PubMed ID: 7988621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study.
    Grossarth-Maticek R; Kiene H; Baumgartner SM; Ziegler R
    Altern Ther Health Med; 2001; 7(3):57-66, 68-72, 74-6 passim. PubMed ID: 11347286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.